We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Indevus, Endo Face Another Class Action Over Merger

Law360 (February 3, 2009, 12:00 AM EST) -- Indevus Pharmaceuticals Inc. is facing another proposed shareholder class action seeking to block a merger with Endo Pharmaceuticals Holdings Inc., claiming Endo's $4.50 a share offer undervalues the specialty drug company....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.